Based on previous research, CCL2 was identified as a PCa biomarker for PCa diagnosis (42), and Pienta's team reported that CCL2 could promote PCa growth through the regulation of macrophage infiltration (43). The gene discussed is CCL2; the disease is posterior cortical atrophy.